It is used for in vitro qualitative detection of influenza A and Influenza B virus antigens in human Nasopharyngeal swab and oropharyngeal swab samples.

The prevalence of Influenza A virus is stronger than that of Influenza B virus, resulting in more serious illness, while Influenza B virus is relatively mild. The standard method for laboratory diagnosis is virus isolation and culture, and the cell culture and identification cycle is about 14 days, which seriously affects the timely medication guidance for patients in clinical practice. This method is limited in clinical application. Compared with the cell culture method, reverse transcription Polymerase chain reaction (RT-PCR) is more sensitive, but the cost of RT-PCR is higher, and the experimental time needs 4-6 hours, and it is highly professional for experimental operation. Therefore, on-site applications are limited.

  • Product Introduction
  • Product Features
  • FAQ/Experimental Cases
  • Manual Download
FluANameArticle numberTypesRecommended Use
H1N1 Cap antibodyA047P01Murine monoclonal antibodyImmunochromatography National Disk
H1N1 Det antibodyA047P02Murine monoclonal antibody
FluBHepatitis B Cap antibodyA048P01Murine monoclonal antibody
Et antibodyA048P02Murine monoclonal antibody

The correlation between Influenza A virus antigen accuracy and RT-PCR is as follows:

Sensitivity=(95/104) × 100%=91.35%

Specificity=(129/131) × 100%=98.47%

Overall consistency=(224/235) × 100%=95.32%

The correlation between Influenza B virus antigen accuracy and RT-PCR is as follows:

Sensitivity=(39/44) × 100%=88.64%

Specificity=(186/191) × 100%=97.38%

Overall consistency=(225/235) × 100%=95.74%

A048P01 Acetate ...

File Name:

A048P02 Ethylene...

File Name:

A047P02 H1N1 Det...

File Name:

A047P01 H1N1 Cap...

File Name:

Related Recommend